Pascal Yoshida
- The occurrence of pneumonia in COPD patients treated with salmeterol xinafoate 50mcg/fluticasone propionate 250mcg (SFC250) - Interim report of post-marketing surveillance in JapanBy Yoriko Morioka, Terufumi Hara, Hideo Kikkawa, Hideki Hitosugi and Pascal YoshidaYoriko Morioka1Clinical Safety and PMS Unit, GlaxoSmithKline K.K., Tokyo, JapanTerufumi Hara1Clinical Safety and PMS Unit, GlaxoSmithKline K.K., Tokyo, JapanHideo Kikkawa2Medical affairs Unit, GlaxoSmithKline K.K., Tokyo, JapanHideki Hitosugi2Medical affairs Unit, GlaxoSmithKline K.K., Tokyo, JapanPascal Yoshida1Clinical Safety and PMS Unit, GlaxoSmithKline K.K., Tokyo, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.